Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Other Non-Current Liabilities (2019 - 2025)

Biodesix's Other Non-Current Liabilities history spans 7 years, with the latest figure at $1.0 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 25.28% year-over-year to $1.0 million; the TTM value through Dec 2025 reached $1.0 million, up 25.28%, while the annual FY2025 figure was $1.0 million, 25.28% up from the prior year.
  • Other Non-Current Liabilities reached $1.0 million in Q4 2025 per BDSX's latest filing, up from $769000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $30.9 million in Q1 2021 to a low of $60000.0 in Q3 2022.
  • Average Other Non-Current Liabilities over 5 years is $5.6 million, with a median of $918000.0 recorded in 2024.
  • Peak YoY movement for Other Non-Current Liabilities: surged 8536.67% in 2023, then crashed 96.24% in 2024.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $1.4 million in 2021, then tumbled by 59.83% to $558000.0 in 2022, then rose by 27.6% to $712000.0 in 2023, then rose by 14.47% to $815000.0 in 2024, then increased by 25.28% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Other Non-Current Liabilities are $1.0 million (Q4 2025), $769000.0 (Q3 2025), and $549000.0 (Q2 2025).